A cis‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma
Abstract Purpose The overexpression and knockdown of PLK4 were both reported to generate aneuploidy. Thus, we aimed to investigate whether genetic variants in PLK4 contribute to the development of hepatocellular carcinoma (HCC). Methods We evaluated associations of common variants in PLK4 and its pr...
Main Authors: | Lijuan Meng, Yan Zhou, Sihan Ju, Jing Han, Ci Song, Jing Kong, Yifei Wu, Shuai Lu, Jiani Xu, Wenwen Yuan, Erbao Zhang, Cheng Wang, Zhibin Hu, Yayun Gu, Rongcheng Luo, Xuehao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2487 |
Similar Items
-
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
by: Amreena Suri, et al.
Published: (2019-04-01) -
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer
by: Armen Parsyan, et al.
Published: (2021-08-01) -
Control-Flow Integrity: Attacks and Protections
by: Sarwar Sayeed, et al.
Published: (2019-10-01) -
Investigating the role of Plk4 in vivo
by: Gambarotto, Davide
Published: (2016) -
The interrelationship between APC/C and Plk1 activities in centriole disengagement
by: Toshiyuki Hatano, et al.
Published: (2012-09-01)